Les anticoagulants oraux directs (AOD)

Simple item page
dc.contributor.advisorJaouad EL HARTI
dc.contributor.authorMANGARA Badon
dc.date.accessioned2023-09-15T13:41:53Z
dc.date.accessioned2026-01-22T13:33:57Z
dc.date.available2023-09-15T13:41:53Z
dc.date.issued2021
dc.description.collaboratorYassir BOUSLIMAN
dc.description.collaboratorMustapha BOUATIA
dc.description.collaboratorIlyasse ASFALOU
dc.identifier.urihttps://toubkal.imist.ma/handle/123456789/19178
dc.identifier.urihttps://doi.org/10.83129/toubkal-11506
dc.language.isofr
dc.publisherUniversité Mohammed 5 de Rabat, Faculté de Médecine et de Pharmacie, Rabatfr_FR
dc.subjectAntivitamine kfr_FR
dc.subjectDabigatranfr_FR
dc.subjectRivaroxabanfr_FR
dc.subjectApixabanfr_FR
dc.subjectEntretien pharmaceutiquefr_FR
dc.subject.otherSciences médicales
dc.subject.specificMédecine
dc.titleLes anticoagulants oraux directs (AOD)fr_FR

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
P0992021.pdf
Size:
3.61 MB
Format:
Adobe Portable Document Format
Download

Collections

Faculté de Médecine et de Pharmacie - Rabat